SPONSOR: Brown (16)
This bill specifies that for MO HealthNet and for insurance carriers or health benefit plans, any prior authorization requirements for opioid analgesic and any service denials made thereto do not require the use of opioid analgesic drug products without abuse-deterrent properties before authorizing the use of such drug products.
The bill also requires insurance carriers or health benefits plans to provide coverage on their formulary or drug list at least one abuse-deterrent opioid analgesic drug product per opioid analgesics active ingredient.
Cost-sharing for brand name or generic versions of this product are not to exceed the lowest cost-sharing level applied to brand name or generic non-abuse deterrent opioid drugs covered under the applicable health plan or policy. Additionally, an increase in patient cost-sharing or disincentives for prescribers or dispensers is not allowed in order to achieve compliance with the provisions of this bill.
Statutes affected: